Annual EBIT
-$10.52 M
+$2.64 M+20.04%
December 31, 2023
Summary
- As of February 7, 2025, NDRA annual earnings before interest & taxes is -$10.52 million, with the most recent change of +$2.64 million (+20.04%) on December 31, 2023.
- During the last 3 years, NDRA annual EBIT has risen by +$972.40 thousand (+8.46%).
- NDRA annual EBIT is now -589.34% below its all-time high of -$1.53 million, reached on December 31, 2014.
Performance
NDRA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.51 M
+$721.90 K+32.36%
September 30, 2024
Summary
- As of February 7, 2025, NDRA quarterly earnings before interest & taxes is -$1.51 million, with the most recent change of +$721.90 thousand (+32.36%) on September 30, 2024.
- Over the past year, NDRA quarterly EBIT has increased by +$1.62 million (+51.78%).
- NDRA quarterly EBIT is now -381.95% below its all-time high of -$313.10 thousand, reached on December 31, 2016.
Performance
NDRA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$7.98 M
+$1.62 M+16.88%
September 30, 2024
Summary
- As of February 7, 2025, NDRA TTM earnings before interest & taxes is -$7.98 million, with the most recent change of +$1.62 million (+16.88%) on September 30, 2024.
- Over the past year, NDRA TTM EBIT has increased by +$4.40 million (+35.54%).
- NDRA TTM EBIT is now -1363.89% below its all-time high of -$545.00 thousand, reached on September 30, 2015.
Performance
NDRA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NDRA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | +51.8% | +35.5% |
| 3 y3 years | +8.5% | +51.8% | +35.5% |
| 5 y5 years | -16.0% | +51.8% | +35.5% |
NDRA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.0% | -3.5% | +57.8% | at high | +39.8% |
| 5 y | 5-year | at high | +20.0% | -3.5% | +57.8% | at high | +39.8% |
| alltime | all time | -589.3% | +20.0% | -381.9% | +57.8% | -1363.9% | +39.8% |
ENDRA Life Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.51 M(-32.4%) | -$7.98 M(-16.9%) |
| Jun 2024 | - | -$2.23 M(-19.8%) | -$9.60 M(-7.4%) |
| Mar 2024 | - | -$2.78 M(+90.7%) | -$10.36 M(-1.5%) |
| Dec 2023 | -$10.52 M(-20.0%) | -$1.46 M(-53.4%) | -$10.52 M(-15.0%) |
| Sep 2023 | - | -$3.13 M(+4.5%) | -$12.38 M(-2.3%) |
| Jun 2023 | - | -$2.99 M(+1.9%) | -$12.66 M(-4.4%) |
| Mar 2023 | - | -$2.94 M(-11.3%) | -$13.24 M(+0.6%) |
| Dec 2022 | -$13.16 M(+14.4%) | -$3.31 M(-3.0%) | -$13.16 M(+1.9%) |
| Sep 2022 | - | -$3.42 M(-4.3%) | -$12.92 M(+6.3%) |
| Jun 2022 | - | -$3.57 M(+25.1%) | -$12.15 M(+3.2%) |
| Mar 2022 | - | -$2.86 M(-7.0%) | -$11.78 M(+2.4%) |
| Dec 2021 | -$11.50 M(+0.0%) | -$3.07 M(+15.9%) | -$11.50 M(+7.7%) |
| Sep 2021 | - | -$2.65 M(-17.2%) | -$10.68 M(-5.4%) |
| Jun 2021 | - | -$3.20 M(+24.2%) | -$11.28 M(+2.8%) |
| Mar 2021 | - | -$2.58 M(+14.4%) | -$10.97 M(-4.5%) |
| Dec 2020 | -$11.49 M(+5.0%) | -$2.25 M(-30.9%) | -$11.49 M(-7.5%) |
| Sep 2020 | - | -$3.26 M(+12.7%) | -$12.42 M(+4.8%) |
| Jun 2020 | - | -$2.89 M(-6.6%) | -$11.85 M(+4.9%) |
| Mar 2020 | - | -$3.09 M(-2.8%) | -$11.30 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$10.95 M(+20.8%) | -$3.18 M(+18.5%) | -$10.95 M(+11.9%) |
| Sep 2019 | - | -$2.69 M(+15.0%) | -$9.79 M(+3.2%) |
| Jun 2019 | - | -$2.33 M(-15.1%) | -$9.48 M(+5.7%) |
| Mar 2019 | - | -$2.75 M(+36.1%) | -$8.97 M(-1.0%) |
| Dec 2018 | -$9.07 M(+96.0%) | -$2.02 M(-15.2%) | -$9.06 M(-3.0%) |
| Sep 2018 | - | -$2.38 M(+30.6%) | -$9.34 M(+18.7%) |
| Jun 2018 | - | -$1.82 M(-35.8%) | -$7.87 M(+10.8%) |
| Mar 2018 | - | -$2.84 M(+23.6%) | -$7.10 M(+53.6%) |
| Dec 2017 | -$4.63 M(+158.2%) | -$2.30 M(+152.1%) | -$4.63 M(+75.1%) |
| Sep 2017 | - | -$910.90 K(-13.8%) | -$2.64 M(+13.1%) |
| Jun 2017 | - | -$1.06 M(+193.0%) | -$2.34 M(+31.7%) |
| Mar 2017 | - | -$360.70 K(+15.2%) | -$1.77 M(-0.7%) |
| Dec 2016 | -$1.79 M(+14.2%) | -$313.10 K(-48.3%) | -$1.79 M(-7.4%) |
| Sep 2016 | - | -$605.10 K(+22.4%) | -$1.93 M(+3.2%) |
| Jun 2016 | - | -$494.30 K(+32.3%) | -$1.87 M(+36.0%) |
| Mar 2016 | - | -$373.50 K(-18.0%) | -$1.37 M(+37.3%) |
| Dec 2015 | -$1.57 M(+2.8%) | -$455.40 K(-16.4%) | -$1.00 M(+83.6%) |
| Sep 2015 | - | -$545.00 K | -$545.00 K |
| Dec 2014 | -$1.53 M | - | - |
FAQ
- What is ENDRA Life Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for ENDRA Life Sciences?
- What is ENDRA Life Sciences annual EBIT year-on-year change?
- What is ENDRA Life Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly EBIT year-on-year change?
- What is ENDRA Life Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ENDRA Life Sciences?
- What is ENDRA Life Sciences TTM EBIT year-on-year change?
What is ENDRA Life Sciences annual earnings before interest & taxes?
The current annual EBIT of NDRA is -$10.52 M
What is the all time high annual EBIT for ENDRA Life Sciences?
ENDRA Life Sciences all-time high annual earnings before interest & taxes is -$1.53 M
What is ENDRA Life Sciences annual EBIT year-on-year change?
Over the past year, NDRA annual earnings before interest & taxes has changed by +$2.64 M (+20.04%)
What is ENDRA Life Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of NDRA is -$1.51 M
What is the all time high quarterly EBIT for ENDRA Life Sciences?
ENDRA Life Sciences all-time high quarterly earnings before interest & taxes is -$313.10 K
What is ENDRA Life Sciences quarterly EBIT year-on-year change?
Over the past year, NDRA quarterly earnings before interest & taxes has changed by +$1.62 M (+51.78%)
What is ENDRA Life Sciences TTM earnings before interest & taxes?
The current TTM EBIT of NDRA is -$7.98 M
What is the all time high TTM EBIT for ENDRA Life Sciences?
ENDRA Life Sciences all-time high TTM earnings before interest & taxes is -$545.00 K
What is ENDRA Life Sciences TTM EBIT year-on-year change?
Over the past year, NDRA TTM earnings before interest & taxes has changed by +$4.40 M (+35.54%)